Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BioNTech SE BNTX

Healthcare Biotechnology
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a... see more

Recent & Breaking News (NDAQ:BNTX)

UPCOMING BNTX DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds BioNTech SE Investors to Join the Class Action Lawsuit!

Accesswire February 25, 2024

Class Action Filed Against BioNTech SE (BNTX) - March 12, 2024 Deadline to Join - Contact Levi & Korsinsky

Accesswire February 24, 2024

BNTX DEADLINE NOTICE: ROSEN, A LEADING NATIONAL FIRM, Encourages BioNTech SE Investors with Losses in Excess of $100K to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX

PR Newswire February 24, 2024

Kessler Topaz Meltzer & Check, LLP: Announces Securities Fraud Class Action Lawsuit Filed Against BioNTech SE

Accesswire February 24, 2024

BioNTech Shareholder Alert

Newsfile February 24, 2024

Levi & Korsinsky Notifies BioNTech SE Investors of a Class Action Lawsuit and Upcoming Deadline - BNTX

Accesswire February 23, 2024

BioNTech SE Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before March 12, 2024 to Discuss Your Rights - BNTX

Accesswire February 23, 2024

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in BioNTech SE with Losses of $100,000 to Contact the Firm

Newsfile February 23, 2024

BNTX Investors Have Opportunity to Lead BioNTech SE Securities Fraud Lawsuit

PR Newswire February 23, 2024

Shareholders that lost money on BioNTech SE (BNTX) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

PR Newswire February 23, 2024

Levi & Korsinsky Reminds BioNTech Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 12, 2024 - BNTX

Accesswire February 23, 2024

UPCOMING BNTX DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds BioNTech SE Investors to Join the Class Action Lawsuit!

Accesswire February 23, 2024

Contact Levi & Korsinsky by March 12, 2024 Deadline to Join Class Action Against BioNTech SE(BNTX)

Accesswire February 22, 2024

BioNTech SE Sued for Securities Law Violations - Contact Levi & Korsinsky Before March 12, 2024 to Discuss Your Rights - BNTX

Accesswire February 22, 2024

Contact Levi & Korsinsky by March 12, 2024 Deadline to Join Class Action Against BioNTech SE (BNTX)

Accesswire February 22, 2024

INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in BioNTech SE with Losses of $100,000 to Contact the Firm

Newsfile February 22, 2024

Shareholders that lost money on BioNTech SE(BNTX) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

Accesswire February 22, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTech SE of Class Action Lawsuit and Upcoming Deadlines - BNTX

Accesswire February 22, 2024

Levi & Korsinsky Notifies Shareholders of BioNTech SE(BNTX) of a Class Action Lawsuit and an Upcoming Deadline

Accesswire February 22, 2024

DEADLINE ALERT: Bernstein Liebhard LLP Reminds BioNTech SE Investors of Upcoming Deadline

Accesswire February 22, 2024